A CRA financial services expert performed analysis and expert testimony support related to damages from the exchange of executive stock options in a merger. Our analysis estimated damages at 5% to 10% of the plaintiffs’ $500 million damages claim. The client settled on terms near our estimate.
Smallest saleable patent-practicing unit in life sciences disputes
In this article titled “Smallest saleable patent-practicing unit in life sciences disputes,” author Erin McDermott examines methods for calculating damages in...